Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,186 | -38,761 | -31,237 | -27,499 | -20,530 |
| Depreciation Amortization | 1,104 | 1,729 | 1,582 | 1,860 | 2,171 |
| Accounts payable and accrued liabilities | -672 | -1,015 | 117 | 1,287 | 682 |
| Other Working Capital | -3,039 | -966 | -2,311 | -4,573 | 7,331 |
| Other Operating Activity | 4,332 | 4,558 | 4,765 | 7,980 | -63 |
| Operating Cash Flow | $-35,461 | $-34,456 | $-27,085 | $-20,944 | $-10,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 697 | -1,506 | -2,305 | -1,702 | -1,170 |
| Purchase Of Investment | -25,903 | -92,680 | -68,036 | -36,578 | -35,265 |
| Sale Of Investment | 57,477 | 113,841 | 41,669 | 35,188 | 29,323 |
| Other Investing Activity | 0 | 0 | 0 | 85 | 0 |
| Investing Cash Flow | $32,272 | $19,656 | $-28,671 | $-3,007 | $-7,111 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,482 | 563 | 2,073 | 2,535 |
| Debt Repayment | -2,307 | -1,016 | -1,096 | -5,429 | -2,224 |
| Common Stock Issued | 67 | 19,985 | 44,659 | 37,424 | 329 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 13,991 |
| Financing Cash Flow | $-2,240 | $20,451 | $44,127 | $34,068 | $14,631 |
| Beginning Cash Position | 11,726 | 6,075 | 17,705 | 7,588 | 10,478 |
| End Cash Position | 6,297 | 11,726 | 6,075 | 17,705 | 7,588 |
| Net Cash Flow | $-5,429 | $5,651 | $-11,629 | $10,117 | $-2,890 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,461 | -34,456 | -27,085 | -20,944 | -10,410 |
| Capital Expenditure | -179 | -1,511 | -2,305 | -1,704 | -1,170 |
| Free Cash Flow | -35,640 | -35,967 | -29,389 | -22,648 | -11,580 |